The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Loss of function of the maternally inherited allele for the UBE3A ubiquitin ligase gene causes Angelman syndrome (AS), which is characterized by severe neurological impairment and motor dysfunction. In addition, UBE3A lies within chromosome 15q11-q13 region, where maternal, but not paternal, duplications cause autism. The UBE3A gene product, E6-AP, has been shown to function both as an E3 ligase in the ubiquitin proteasome pathway and as a transcriptional coactivator. However, the specific role of E6-AP in the brain, or how loss of function of E6-AP results in AS, is unclear. Herein, we show, using a recombinant transgenic mouse expressing a Ube3a(YFP) fusion gene, that the maternal Ube3a(YFP) allele is upregulated and preferentially expressed in neurons, and that the fusion protein, E6-AP:YFP, is enriched in the nucleus and dendrites in vivo. We also show that E6-AP:YFP localizes to the nucleus and to presynaptic and postsynaptic compartments in cultured hippocampal neurons. Furthermore, we show that cerebellar Purkinje cell number and dendritic branching are not affected in Ube3a maternal-deficient mice, but that dendritic spine development, including spine morphology, number and length, is affected on cerebellar Purkinje cells and on pyramidal neurons in the hippocampus and cortex. Collectively, these data suggest that the neurological deficits observed in AS patients and in AS mice may result from specific abnormalities in synaptic development and/or plasticity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UBE3A encodes an E3 ubiquitin ligase whose maternal deficiency reduces dendritic spine density and length in cerebellar and hippocampal pyramidal neurons45, suggesting a potential link between Angelman syndrome, autism and altered synaptic structure.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [45]
In the citing paper
“The Angelman syndrome mouse, which lacks the maternal UBE3A gene, displays motor deficits, impaired context-dependent learning, impaired plasticity and altered spine density on hippocampal and cortical pyramidal neurons45,85.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [45]
In the citing paper
“In the cerebellum, cell density and dendritic complexity are unaffected in Ube3am−/p+ mice [86].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [86]
In the citing paper
“spine density is decreased in layer V after 21 days of age [86, 196, 312]”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [86]
Citations
Cites
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852 · cited 4×
“2 ES cells as described previously (9).”
BackgroundResultInfluentialSelf-citation(1997) · PubMed · Cited by 645
Angelman syndrome 2005: Updated consensus for diagnostic criteria
Williams, C. A., Beaudet, A. L., Clayton‐Smith, J., Knoll, J. H., Kyllerman, M., Laan, L. A., Magenis, R. E., Moncla, A., Schinzel, A. A., Summers, J. A., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31074 · Cited by 627
Self-citationAlbrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0997-75 · Cited by 583
Self-citationUbiquitination Regulates PSD-95 Degradation and AMPA Receptor Surface Expression
Colledge, M., Snyder, E. M., Crozier, R. A., Soderling, J. A., Jin, Y., Langeberg, L. K., Lu, H., Bear, M. F., & Scott, J. D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00687-1 · Cited by 567 · cited 1×
“The presence of E6-AP at the synapse further supports this idea (20), although we cannot exclude a possible contribution of a nuclear role for E6-AP in regulating the structure and/or function of the synapse.”
BackgroundAbnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560
Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome
Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., & Zoghbi, H. Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2623-05.2006 · Cited by 545
Self-citationAnalysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527
Cummings, C. J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y.-H., Ciechanover, A., Orr, H. T., Beaudet, A. L., & Zoghbi, H. Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81035-1 · Cited by 501
Self-citation
Cited by
Items 101–200 of 459
Santini, E., Turner, K. L., Ramaraj, A. B., Murphy, M. P., Klann, E., & Kaphzan, H. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2246-15.2015 · Cited by 75
Sun, J., Liu, Y., Moreno, S., Baudry, M., & Bi, X. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-14.2015 · Cited by 75
Rotaru, D. C., van Woerden, G. M., Wallaard, I., & Elgersma, Y. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0083-18.2018 · Cited by 74
Synaptic Signaling and Aberrant RNA Splicing in Autism Spectrum Disorders
Smith, R. M., & Sadée, W. (2011) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2011.00001 · Cited by 75
Roles of ubiquitination at the synapse
Haas, K. F., & Broadie, K. S. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.12.010 · Cited by 73
Mechanisms underlying the EEG biomarker in Dup15q syndrome
Frohlich, J., Reiter, L. T., Saravanapandian, V., DiStefano, C., Huberty, S., Hyde, C., Chamberlain, S. J., Bearden, C. E., Golshani, P., Irimia, A., et al. (2019) · Molecular Autism · doi:10.1186/s13229-019-0280-6 · Cited by 72
CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice
Schmid, R. S., Deng, X., Panikker, P., Msackyi, M., Breton, C. A., & Wilson, J. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142574 · Cited by 72
Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome
Mulherkar, S. A., & Jana, N. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.002 · Cited by 71
From UBE3A to Angelman syndrome: a substrate perspective
Sell, G. L., & Margolis, S. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00322 · Cited by 70
Epigenetic Basis of Neuronal and Synaptic Plasticity
Karpova, N. N., Sales, A. J., & Joca, S. R. L. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160414124628 · Cited by 70
Alterations in white matter pathways in Angelman syndrome
PETERS, S. U., KAUFMANN, W. E., BACINO, C. A., ANDERSON, A. W., ADAPA, P., CHU, Z., YALLAMPALLI, R., TRAIPE, E., HUNTER, J. V., & WILDE, E. A. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03838.x · Cited by 69
“A recent study in a mouse model of Angelman syndrome indicates that the maternal Ube3a (YFP) allele is preferentially expressed in neurons and in most brain regions and that dendritic spine development, including spine morphology, number, and length, is affected in cerebellar Purkinje cells and in pyramidal neurons in…”
BackgroundShioda, N., Beppu, H., Fukuda, T., Li, E., Kitajima, I., & Fukunaga, K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4816-10.2011 · Cited by 68
Proteomic Studies of a Single CNS Synapse Type: The Parallel Fiber/Purkinje Cell Synapse
Selimi, F., Cristea, I. M., Heller, E., Chait, B. T., & Heintz, N. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000083 · Cited by 67
Godavarthi, S. K., Dey, P., Maheshwari, M., & Ranjan Jana, N. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr614 · Cited by 66
Kim, H., Kunz, P. A., Mooney, R., Philpot, B. D., & Smith, S. L. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4204-15.2016 · Cited by 65
“The loss of UBE3A may cause generalized reductions in dendritic spine density given that AS model mice also exhibit reduced spine density in the cerebellum and hippocampus (Dindot et al., 2008).”
BackgroundInfluentialAn open-label pilot trial of minocycline in children as a treatment for Angelman syndrome
Grieco, J. C., Ciarlone, S. L., Gieron-Korthals, M. A., Schoenberg, M. R., Smith, A., Philpot, R. M., Heussler, H., Banko, J. L., & Weeber, E. J. (2014) · BMC Neurology · doi:10.1186/s12883-014-0232-x · Cited by 65
Li, W., Yao, A., Zhi, H., Kaur, K. H., Zhu, Y.-C., Jia, M., Zhao, H., Wang, Q., Jin, S., Zhao, G., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006062 · Cited by 64
Condon, K. H., Ho, J., Robinson, C. G., Hanus, C., & Ehlers, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1930-11.2013 · Cited by 63
Epigenetic therapy of Prader–Willi syndrome
Kim, Y., Wang, S. E., & Jiang, Y. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.012 · Cited by 63
Epigenetic regulation in memory and cognitive disorders
Rudenko, A., & Tsai, L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.034 · Cited by 62
Martínez-Noël, G., Luck, K., Kühnle, S., Desbuleux, A., Szajner, P., Galligan, J. T., Rodriguez, D., Zheng, L., Boyland, K. A., Leclere, F., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.021 · Cited by 61
Abnormal Language Pathway in Children With Angelman Syndrome
Wilson, B. J., Sundaram, S. K., Huq, A. H. M., Jeong, J.-W., Halverson, S. R., Behen, M. E., Bui, D. Q., & Chugani, H. T. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2010.12.002 · Cited by 60
“cerebellum and cortex [17] and is involved in the ubiquitin proteosome system which is the primary mechanism by which protein degradation is regulated inside the cell.”
BackgroundMagdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
Sun, J., Liu, Y., Jia, Y., Tran, J., Hao, X., Lin, W., LYNCH, G. S., Baudry, M., & Bi, X. (2018) · eLife · doi:10.7554/elife.37993 · Cited by 60
Structural dynamics of dendritic spines: Molecular composition, geometry and functional regulation
Ebrahimi, S., & Okabe, S. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.06.002 · Cited by 62
Hara, Y., Ago, Y., Taruta, A., Katashiba, K., Hasebe, S., Takano, E., Onaka, Y., Hashimoto, H., Matsuda, T., & Takuma, K. (2016) · Autism Research · doi:10.1002/aur.1596 · Cited by 59
Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome
Romero, L. O., Caires, R., Victor, A. K., Ramírez, J., Sierra-Valdez, F. J., Walsh, P., Truong, V., Lee, J., Mayor, U., Reiter, L. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36818-0 · Cited by 59
A therapeutic trial of pro‐methylation dietary supplements in Angelman syndrome
Bird, L. M., Tan, W., Bacino, C. A., Peters, S. U., Skinner, S. A., Anselm, I. A., Barbieri‐Welge, R. L., Bauer‐Carlin, A., Gentile, J. K., Glaze, D. G., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34297 · Cited by 59
Self-citationRoxrud, I., Raiborg, C., Gilfillan, G. D., Strømme, P., & Stenmark, H. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.012 · Cited by 59
Mahmood, U., Ahn, S., Yang, E.-J., Choi, M., Kim, H.-J., Regan, P. L., Cho, K., & Kim, H.-S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.006 · Cited by 57
Wang, J., Lou, S., Wang, T., Wu, R., Li, G., Zhao, M., Lü, B., Li, Y., Zhang, J., Cheng, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820131116 · Cited by 57
Lee, P. C.-W., Dodart, J., Aron, L., Finley, L. W. S., Bronson, R. T., Haigis, M. C., Yankner, B. A., & Harper, J. W. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.014 · Cited by 57
Hethorn, W. R., Ciarlone, S. L., Filonova, I., Rogers, J. T., Aguirre, D., Ramirez, R. A., Grieco, J. C., Peters, M. M., Gulick, D., Anderson, A. E., et al. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12893 · Cited by 56
Understanding the Pathogenesis of Angelman Syndrome through Animal Models
Jana, N. R. (2012) · Neural Plasticity · doi:10.1155/2012/710943 · Cited by 57
Angelman syndrome: Current and emerging therapies in 2016
Tan, W., & Bird, L. M. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31536 · Cited by 56
Epigenetic mechanisms of gene expression regulation in neurological diseases
Goś, M. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1919 · Cited by 54
Ellingford, R. A., Panasiuk, M. J., de Meritens, E. R., Shaunak, R., Naybour, L., Browne, L., Basson, M. A., & Andreae, L. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01070-9 · Cited by 53
The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders
Owais, A., Mishra, R. K., & Kiyokawa, H. (2020) · Cancers · doi:10.3390/cancers12082108 · Cited by 53
Mardirossian, S., Rampon, C., Salvert, D., Fort, P., & Sarda, N. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.035 · Cited by 53
Nakai, N., Takumi, T., Nakai, J., & Sato, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00412 · Cited by 52
Farook, M. F., DeCuypere, M. G., Hyland, Κ., Takumi, T., LeDoux, M. S., & Reiter, L. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043030 · Cited by 52
Spatial organization of ubiquitin ligase pathways orchestrates neuronal connectivity
Yamada, T., Yang, Y., & Bonni, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.004 · Cited by 51
Genetically Dissecting Cortical Neurons Involved in Epilepsy in Angelman Syndrome
Santini, E., & Klann, E. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.023 · Cited by 51
Schulte, C., Ripamonti, M., Maffioli, E., Cappelluti, M. A., Nonnis, S., Puricelli, L., Lamanna, J., Piazzoni, C., Podestà, A., Lenardi, C., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00267 · Cited by 49
CIM6P / IGF ‐2 Receptor Ligands Reverse Deficits in Angelman Syndrome Model Mice
Cruz, E., Descalzi, G., Steinmetz, A. B., Scharfman, H. E., Katzman, A. C., & Alberini, C. M. (2020) · Autism Research · doi:10.1002/aur.2418 · Cited by 49
Therapies in preclinical and clinical development for Angelman syndrome
Markati, T., Duis, J. B., & Servais, L. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1939674 · Cited by 49
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model
Bruinsma, C. F., Schonewille, M., Gao, Z., Aronica, E., Judson, M. C., Philpot, B. D., Hoebeek, F. E., van Woerden, G. M., Zeeuw, C. I. D., & Elgersma, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83541 · Cited by 48
Drosophila Studies on Autism Spectrum Disorders
Tian, Y., Zhang, Z. C., & Han, J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0166-6 · Cited by 46
Bossuyt, S. N. V., Punt, A. M., de Graaf, I. J., van den Burg, J., Williams, M., Heussler, H., Elgersma, Y., & Distel, B. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab050 · Cited by 46
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
Copping, N. A., McTighe, S. M., Fink, K. D., & Silverman, J. L. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01082-x · Cited by 45
Double‐blind therapeutic trial in Angelman syndrome using betaine and folic acid
Peters, S. U., Bird, L. M., Kimonis, V., Glaze, D. G., Shinawi, L. M., Bichell, T. J., Barbieri‐Welge, R., Nespeca, M., Anselm, I., Waisbren, S., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33509 · Cited by 44
Self-citationMaheshwari, M., Samanta, A., Godavarthi, S. K., Mukherjee, R., & Jana, N. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371724 · Cited by 44
Lee, H.-M., Clark, E. P., Kuijer, M. B., Cushman, M., Pommier, Y. G., & Philpot, B. D. (2018) · Molecular Autism · doi:10.1186/s13229-018-0228-2 · Cited by 44
Ferdousy, F., Bodeen, W., Summers, K., Doherty, O., Wright, O., Elsisi, N., Hilliard, G., O'Donnell, J. M., & Reiter, L. T. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.12.001 · Cited by 43
A new synaptic player leading to autism risk: Met receptor tyrosine kinase
Judson, M. C., Eagleson, K. L., & Levitt, P. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9081-8 · Cited by 43
Zhao, P., Hill, M., Liu, S., Chen, L., Bangalore, L., Waxman, S. G., & Tan, A. M. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01057.2015 · Cited by 43
Dramatic loss of Ube3A expression during aging of the mammalian cortex
Williams, K., Irwin, D. A., Jones, D. G., & Murphy, K. M. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00018 · Cited by 42
Jensen, L. C., Farook, M. F., & Reiter, L. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061952 · Cited by 42
Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling
Furusawa, K., Ishii, K., Tsuji, M., Tokumitsu, N., Hasegawa, E., & Emoto, K. (2023) · Science · doi:10.1126/science.ade8978 · Cited by 42
Sonzogni, M., Zhai, P., Mientjes, E., van Woerden, G. M., & Elgersma, Y. (2020) · Molecular Autism · doi:10.1186/s13229-020-00376-9 · Cited by 41
Lee, D., Chen, W., Kaku, H. N., Zhuo, X., Chao, E. S., Soriano, A., Kuncheria, A., Flores, S., Kim, J. H., Rivera, A. M., et al. (2023) · eLife · doi:10.7554/elife.81892 · Cited by 40
Self-citationClarke, M. T., Remesal, L., Lentz, L., Tan, D., Young, D. M., Thapa, S., Namuduri, S. R., Borges, B., Kirn, G. A., Valencia, J. A., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.02.004 · Cited by 39
Self-citationAutism Spectrum Disorder-Related Syndromes: Modeling with Drosophila and Rodents
Ueoka, I., Pham, H. T. N., Matsumoto, K., & Yamaguchi, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174071 · Cited by 39
Frohlich, J., Chiang, J. N., Mediano, P. A. M., Nespeca, M., Saravanapandian, V., Toker, D., Dell’Italia, J., Hipp, J. F., Jeste, S., Chu, C. J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04331-7 · Cited by 38
Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice
Jones, K. A., Han, J. E., DeBruyne, J. P., & Philpot, B. D. (2016) · Scientific Reports · doi:10.1038/srep28238 · Cited by 38
Impact of induced pluripotent stem cells on the study of central nervous system disease
Cundiff, P. E., & Anderson, S. A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.008 · Cited by 37
Hope, K. A., LeDoux, M. S., & Reiter, L. T. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.09.003 · Cited by 37
McReynolds, J. R., Holloway-Erickson, C. M., Parmar, T. U., & McIntyre, C. K. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.02.007 · Cited by 37
Sugiura, H., Yasuda, S., Katsurabayashi, S., Kawano, H., Endo, K., Takasaki, K., Iwasaki, K., Ichikawa, M., Kobayashi, T., Hino, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms7842 · Cited by 37
Dendritic trafficking for neuronal growth and plasticity
Ehlers, M. D. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130081 · Cited by 36
Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy
Javed, S., Selliah, T., Lee, Y., & Huang, W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.009 · Cited by 36
Epigenetic mechanisms in diurnal cycles of metabolism and neurodevelopment
Powell, W. T., & LaSalle, J. M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv234 · Cited by 36
Baucum, A. J., Jalan‐Sakrikar, N., Jiao, Y., Gustin, R. M., Carmody, L., Tabb, D. L., Ham, A. L., & Colbran, R. J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900387-mcp200 · Cited by 36
Maheshwari, M., Shekhar, S., Singh, B. K., Jamal, I., Vatsa, N., Kumar, V., Sharma, A., & Jana, N. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu343 · Cited by 36
Upadhyay, A., Amanullah, A., Chhangani, D., Mishra, R., & Mishra, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.009 · Cited by 35
Salcedo‐Arellano, M. J., Cabal-Herrera, A. M., Punatar, R., Clark, C. J., Romney, C. A., & Hagerman, R. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00968-6 · Cited by 35
The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain
Kawabe, H., & Stegmüller, J. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103602 · Cited by 35
Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model
Filonova, I., Trotter, J. H., Banko, J. L., & Weeber, E. J. (2014) · Learning & Memory · doi:10.1101/lm.032375.113 · Cited by 35
GABRB3 , Epilepsy, and Neurodevelopment
Tanaka, M., DeLorey, T. M., Delgado‐Escueta, A. V., & Olsen, R. W. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0070 · Cited by 35
Takahashi, Y., Hosoki, K., Matsushita, M., Funatsuka, M., Saito, K., Kanazawa, H., Goto, Y., & Saitoh, S. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31221 · Cited by 34
Ube3a unsilencer for the potential treatment of Angelman syndrome
Vihma, H., Li, K., Welton-Arndt, A., Smith, A. L., Bettadapur, K. R., Gilmore, R. B., Gao, E. B., Cotney, J. L., Huang, H.-C., Collins, J. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49788-8 · Cited by 34
Grier, M. D., Carson, R. P., & Lagrange, A. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124649 · Cited by 34
E3 Ubiquitin Ligases in Protein Quality Control Mechanism
Chhangani, D., Joshi, A. P., & Mishra, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8273-x · Cited by 33
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders
Bailus, B. J., & Segal, D. J. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-76 · Cited by 33
Moens, U. L., & Kostenko, S. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0149 · Cited by 33
HECT‐type E3 ubiquitin ligases in nerve cell development and synapse physiology
Ambrozkiewicz, M. C., & Kawabe, H. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.009 · Cited by 33
Properties of beta oscillations in Dup15q syndrome
Saravanapandian, V., Frohlich, J., Hipp, J. F., Hyde, C., Scheffler, A. W., Golshani, P., Cook, E. H., Reiter, L. T., Şentürk, D., & Jeste, S. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-09326-1 · Cited by 32
Zampeta, F. I., Sonzogni, M., Niggl, E., Lendemeijer, B., Smeenk, H., de Vrij, F. M. S., Kushner, S. A., Distel, B., & Elgersma, Y. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa194 · Cited by 32
Dera, H. S. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112688 · Cited by 32
E6AP in the Brain: One Protein, Dual Function, Multiple Diseases
Hokayem, J. A. E., & Nawaz, Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8563-y · Cited by 32
Angelman Syndrome: Identification and Management
Bonello, D., Camilleri, F., & Calleja‐Agius, J. (2017) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.36.3.142 · Cited by 32
Urraca, N., Hope, K. A., Victor, A. K., Belgard, T. G., Memon, R., Goorha, S., Valdez, C., Tran, Q. T., Sánchez, S., Ramírez, J., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0191-y · Cited by 32
Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A
Sen, D., Voulgaropoulos, A., Drobná, Z., & Keung, A. J. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.08.006 · Cited by 32
Ambrozkiewicz, M. C., Borisova, E. V., Schwark, M., Ripamonti, S., Schaub, T., Тихоновна, С. А., Weber, A. I., Rhee, H. J., Altas, B., Yilmaz, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0714-8 · Cited by 32
Novel Insights into the Role of UBE3A in Regulating Apoptosis and Proliferation
Simchi, L., Panov, J., Morsy, O., Feuermann, Y., & Kaphzan, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051573 · Cited by 29
Sell, G. L., Xin, W., Cook, E. K., Zbinden, M. A., Schaffer, T., O’Meally, R. N., Cole, R. N., Bonci, A., & Margolis, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-97898-w · Cited by 30
Potential therapeutic approaches for Angelman syndrome
Bi, X., Sun, J., Ji, A. X., & Baudry, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1115837 · Cited by 29
Guerra, D. J. (2011) · Autism Research and Treatment · doi:10.1155/2011/398636 · Cited by 28
Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation
Low, D., & Chen, K. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.95 · Cited by 28
Dendrite regeneration in C. elegans is controlled by the RAC GTPase CED-10 and the RhoGEF TIAM-1
Brar, H. K., Dey, S., Bhardwaj, S., Pande, D., Singh, P., Dey, S., & Ghosh‐Roy, A. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010127 · Cited by 28
Metadata
- Authors
- Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B., & Beaudet, A. L.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Beaudet, A. L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-27
- Volume
- 17
- Issue
- 1
- Pages
- 111-118
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2143860178
- Cited by
- 418
- References
- 35
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 28 · 2020: 31 · 2019: 19 · 2018: 17 · 2017: 20 · 2016: 29 · 2015: 28 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health (5f32hd049248-02)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 24064, F32 HD-049248, R01HD037283, P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Angelman syndrome, UBE3A, ubiquitin ligase, maternal inheritance, chromosome 15q11-q13, dendritic spine morphology, synaptic development, Purkinje cells, hippocampal neurons, nuclear localization, transcriptional coactivator, autism spectrum disorder, transgenic mouse model
- MeSH terms
- Animals, Base Sequence, Cell Nucleus, Cells, Cultured, Female, Hippocampus, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Purkinje Cells, Recombinant Fusion Proteins, Synapses, DNA Probes, Angelman Syndrome, Mice, Knockout, Genomic Imprinting, Ubiquitin-Protein Ligases, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.